CL2015000985A1 - Compuestos antibacteriales y la aplicacion biologica de los mismos. - Google Patents

Compuestos antibacteriales y la aplicacion biologica de los mismos.

Info

Publication number
CL2015000985A1
CL2015000985A1 CL2015000985A CL2015000985A CL2015000985A1 CL 2015000985 A1 CL2015000985 A1 CL 2015000985A1 CL 2015000985 A CL2015000985 A CL 2015000985A CL 2015000985 A CL2015000985 A CL 2015000985A CL 2015000985 A1 CL2015000985 A1 CL 2015000985A1
Authority
CL
Chile
Prior art keywords
antibacterial compounds
biological application
pharmaceutical
phosphates
gram
Prior art date
Application number
CL2015000985A
Other languages
English (en)
Inventor
Dmytro Atamanyuk
Vincent Gerusz
Francois Moreau
Vivien Henryon
Etienne Airiau
Jerome Monbrun
Original Assignee
Mutabilis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mutabilis filed Critical Mutabilis
Publication of CL2015000985A1 publication Critical patent/CL2015000985A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emergency Medicine (AREA)

Abstract

COMPUESTOS DERIVADOS DE FOSFATOS O ACIDO FOSFONICO SUSUTITUIDOS; PROCEDIMIENTO PARA PREPARARLOS; COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN; MEZCLAS O ASOCIACIONES FARMACEUTICAS QUE LOS COMPRENDEN; Y SU USO PARA LA PREVENCION Y/O EL TRATAMIENTO DE INFECCIONES DEBIDO A BACTERIAS GRAM-NEGATIVAS EN HUMANOS Y ANIMALES.
CL2015000985A 2012-10-29 2015-04-17 Compuestos antibacteriales y la aplicacion biologica de los mismos. CL2015000985A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12306350.5A EP2725029A1 (en) 2012-10-29 2012-10-29 New antibacterial compounds and biological applications thereof

Publications (1)

Publication Number Publication Date
CL2015000985A1 true CL2015000985A1 (es) 2016-05-13

Family

ID=47278726

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015000985A CL2015000985A1 (es) 2012-10-29 2015-04-17 Compuestos antibacteriales y la aplicacion biologica de los mismos.

Country Status (13)

Country Link
US (1) US9975911B2 (es)
EP (2) EP2725029A1 (es)
JP (1) JP6389463B2 (es)
KR (1) KR20150105300A (es)
CN (1) CN104936966A (es)
AU (1) AU2013339557A1 (es)
BR (1) BR112015009546A2 (es)
CA (1) CA2889503A1 (es)
CL (1) CL2015000985A1 (es)
HK (1) HK1211034A1 (es)
MX (1) MX2015005498A (es)
RU (1) RU2015120376A (es)
WO (1) WO2014067904A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0923225A2 (pt) 2008-12-02 2016-10-04 Chiralgen Ltd metodo para sintese de acidos nucleicos modificados no atomo de fosforo
EP2451461A4 (en) 2009-07-06 2013-05-29 Ontorii Inc NOVEL NUCLEIC ACID PRODRUGS AND METHOD OF USE THEREOF
DK2620428T3 (da) 2010-09-24 2019-07-01 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
CN107365339A (zh) 2011-07-19 2017-11-21 波涛生命科学有限公司 合成官能化核酸的方法
WO2014010250A1 (en) 2012-07-13 2014-01-16 Chiralgen, Ltd. Asymmetric auxiliary group
EP3094728B1 (en) 2014-01-16 2022-03-09 Wave Life Sciences Ltd. Chiral design
CN108484620A (zh) * 2018-04-26 2018-09-04 福建师范大学泉港石化研究院 一种水溶性罗丹明基Cu2+荧光探针及其合成方法
CN108484619A (zh) * 2018-04-26 2018-09-04 福建师范大学泉港石化研究院 一种罗丹明基Fe3+荧光探针及其制备方法
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
EP4272831A3 (en) 2018-08-09 2024-02-21 Antabio SAS Diazabicyclooctanones as inhibitors of serine beta-lactamases
RU2770537C1 (ru) * 2021-09-15 2022-04-18 федеральное государственное автономное образовательное учреждение высшего образования «Казанский (Приволжский) федеральный университет» (ФГАОУ ВО КФУ) Фосфорилсодержащие четвертичные соли аммония с высшими алкильными заместителями, обладающие бактерицидной и фунгицидной активностью
CN116905145B (zh) * 2023-08-07 2026-03-06 安徽恒益智能科技股份有限公司 一种抗菌包芯纱线及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206156A (en) * 1976-07-27 1980-06-03 Fujisawa Pharmaceutical Company, Limited Hydroxyaminohydrocarbonphosphonic acids
GB1580899A (en) 1976-07-27 1980-12-10 Fujisawa Pharmaceutical Co Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof
JPS5463024A (en) * 1977-10-27 1979-05-21 Fujisawa Pharmaceut Co Ltd 3-(n-formyl-n-hydroxyamino)-2(r)-hydroxypropyl-phosphonic acid, its preparation, and its use
JPS5562019A (en) * 1978-09-14 1980-05-10 Fujisawa Pharmaceut Co Ltd Antibacterial
US4693742A (en) 1983-12-20 1987-09-15 Rohm And Hass Company Herbicidal hydroxyamino phosphonic acids and derivatives
CA1340588C (en) 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
SK662001A3 (en) * 1998-07-15 2001-10-08 Hassan Jomaa Phosphorous organic compounds and their use
ATE370127T1 (de) 2001-01-29 2007-09-15 Univ Geneve Pyrimidinische azyklonukleoside, verfahren zur ihrer herstellung und ihre verwendung
FR2872158B1 (fr) 2004-06-28 2006-11-03 Merck Sante Soc Par Actions Si Nouveaux composes diazeniumdiolates, leur procede de preparation et leur utilisation therapeutique
EP1669365A1 (en) 2004-12-03 2006-06-14 Mutabilis SA Method for preparing enzymatic substrate analogs as inhibitors of bacterial heptosyl-transferases
SG174772A1 (en) 2006-09-11 2011-10-28 Curis Inc Multi-functional small molecules as anti-proliferative agents
AU2007301607A1 (en) 2006-09-25 2008-04-03 Mutabilis Sa Substituted heterocyclylcarbonylamino-acetic-acid-derivatives as inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors
EP2141164A1 (en) 2008-07-01 2010-01-06 Mutabilis New 1,2,4-triazine derivatives and biological applications thereof
ME02254B (me) * 2009-01-23 2015-12-31 Euro Celtique Sa Derivati hidroksamske kiseline
CA2774250C (en) 2009-10-13 2013-12-17 Pfizer Inc. C-linked hydroxamic acid derivatives useful as antibacterial agents
EP2377853A1 (en) 2010-04-09 2011-10-19 Universite de Rouen 7,11-Methanocycloocta[b]quinoline derivative as highly functionalizable acetylcholinesterase inhibitors
US20140024576A1 (en) 2010-12-01 2014-01-23 Laboratoire Biodim Heptose derivatives for use in the treatment of bacterial infections
US9593136B2 (en) * 2011-07-01 2017-03-14 The George Washington University Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase

Also Published As

Publication number Publication date
WO2014067904A1 (en) 2014-05-08
BR112015009546A2 (pt) 2017-07-04
CN104936966A (zh) 2015-09-23
EP2725029A1 (en) 2014-04-30
EP2912043A1 (en) 2015-09-02
CA2889503A1 (en) 2014-05-08
RU2015120376A (ru) 2016-12-20
HK1211034A1 (en) 2016-05-13
KR20150105300A (ko) 2015-09-16
US9975911B2 (en) 2018-05-22
EP2912043B1 (en) 2016-11-30
JP6389463B2 (ja) 2018-09-12
MX2015005498A (es) 2016-01-08
AU2013339557A1 (en) 2015-04-30
US20150291636A1 (en) 2015-10-15
JP2015536928A (ja) 2015-12-24

Similar Documents

Publication Publication Date Title
CL2014001956A1 (es) Compuestos derivados de beta-lactamicos sustituidos con amidina; metodo para su preparacion; medicamento que los comprende; y su uso para el tratamiento y/o profilaxis de infecciones bacterianas.
CL2018003681A1 (es) Derivados de ácido borónico y usos terapéuticos de los mismos
SV2016005274A (es) Compuestos orgánicos de monobactam para el tratamiento de infecciones bacterianas
CL2017002482A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
MX395249B (es) Composiciones antimicrobianas y sus usos.
CR20140125A (es) Compuestos antibacterianos y métodos para su uso
CL2015000295A1 (es) Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades.
CR20150610A (es) Compuestos de pirimidino sustituido y derivados para combatir plagas de animales
CL2014000311A1 (es) Compuestos derivados de benzotiazepinas sustituidas; composicion farmaceutica que los contiene; y su uso para el tratamiento o profilaxis de la infeccion del virus sincicial respiratorio.
ECSP13012482A (es) Derivados de 5-yodo-triazol
CU20190101A7 (es) Imidazopirimidinas diazabicíclicas sustituidas
CL2017001460A1 (es) Compuestos de acido hidroxámico de isoxazole como inhibidores de lpxc
CL2016000568A1 (es) Compuestos derivados de 2h-indazol-2-il-n-hidroxi-2-metilsulfonil-2-metil-butanamida sustituidos o sus sales; sus composiciones farmacéuticas que los contiene y su uso para la prevención y/o tratamiento de infecciones bacterianas gram-negativas.
DOP2016000253A (es) Nuevos compuestos
UY34169A (es) ?compuestos heterociclicos microbiocidas,composiciones que los contienen, y métodos para controlar o prevenir la infestación de plantas
CL2017002451A1 (es) Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas
CL2017002803A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
BR112017011980A2 (pt) composto, composição farmacêutica, e, método para tratar uma infecção bacteriana.
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
CL2014003113A1 (es) Composición que comprende bacterias inactivadas de alliivibrio wodanis; método de producción; uso para fabricar medicamento para tratar y/o prevenir wodanosis; y vacuna para peces.
CL2018000228A1 (es) Nuevo antibiótico efectivo de aminoglucósido para bacterias resistentes a múltiples fármacos.
EA201401117A1 (ru) Композиции, содержащие пробиотики и комплекс пчелиной пыльцы/глины, способ их приготовления и их применение в питании и терапии
CL2017001276A1 (es) Derivados de benzotiazol antibacterianos
ES2722926T3 (es) Combinación de levocabastina y furoato de fluticasona para el tratamiento de condiciones inflamatorias y/o alérgicas
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt